Diagnostic Products Corporation Announces Record Quarterly Revenue
Published: Apr 27, 2006
LOS ANGELES--(BUSINESS WIRE)--April 27, 2006--Diagnostic Products Corporation (NYSE:DP - News) today reported first quarter sales of $129.6 million, a 14% increase over the first quarter of 2005. Earnings were $18.0 million, or $.60 per diluted share, an increase of 12% from $16.1 million or $.54 reported for the first quarter of 2005. The 2006 results included $1.4 million in compensation expense related to stock options in accordance with the adoption of FAS 123®, "Share-based Payment." The Euro weakened and the Brazilian Real strengthened relative to the dollar, and the net effect of foreign currency movements was a 2% decrease in sales. International sales increased 12% to $90.7 million while domestic sales increased 18% to $38.9 million.